CORT Financial Facts
Net loss and comprehensive loss: -12.08MTotal operating expenses: 12.66M
See Full Income Statement
Property and equipment , net of accumulated depreciation: 154K
Accounts payable: 2.26M
See Full Balance Sheet
Earnings History for Corcept Therapeutics (CORT)
|
Expand Research on CORT
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | +23.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +4.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/2/13 | Q113 | -$0.10 | -$0.09 | -$0.01 | $1.72M | $2.48M | N/A / N/A | N/A | +4.7% | Details | |
| 3/7/13 | Q412 | -$0.09 | -$0.09 | $0.00 | $1.38M | $1.5M | N/A / N/A | N/A | -4.3% | Details | |
10/31/12  |
Q312 | -$0.08 | -$0.09 | +$0.01 | $1.05M | $2.07M | N/A / N/A | N/A | -28.4% | Details | |
| 8/7/12 | Q212 | -$0.09 | -$0.11 | +$0.02 | N/A | N/A | N/A / N/A | N/A | -47% | Details | |
| 5/3/12 | Q112 | -$0.13 | -$0.11 | -$0.02 | N/A | N/A | N/A / N/A | N/A | -50.3% | Details | |
| 3/5/12 | Q411 | -$0.12 | -$0.09 | -$0.03 | N/A | N/A | N/A / N/A | N/A | -55.6% | Details | |
| 11/7/11 |
Q311 | -$0.08 | -$0.10 | +$0.02 | N/A | N/A | N/A / N/A | N/A | -43.4% | Details | |
| 5/4/11 | Q111 | -$0.09 | -$0.10 | +$0.01 | N/A | N/A | N/A / N/A | N/A | -58.3% | Details |
